These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 15161997)
1. Transdermal eperisone elicits more potent and longer-lasting muscle relaxation than oral eperisone. Yang SI; Park HY; Lee SH; Lee SJ; Han OY; Lim SC; Jang CG; Lee WS; Shin YH; Kim JJ; Lee SY Pharmacology; 2004 Jul; 71(3):150-6. PubMed ID: 15161997 [TBL] [Abstract][Full Text] [Related]
2. Long-lasting muscle relaxant activity of eperisone hydrochloride after percutaneous administration in rats. Matsunaga M; Uemura Y; Yonemoto Y; Kanai K; Etoh H; Tanaka S; Atsuta Y; Nishizawa Y; Yamanishi Y Jpn J Pharmacol; 1997 Mar; 73(3):215-20. PubMed ID: 9127816 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological properties of the new centrally acting muscle relaxant (R)-(+)-3-phenyl-5-[2-(1-pyrrolidinylmethyl)butyryl]isoxazole hydrochloride. Otsu T; Kawabata H; Horikomi K; Tanada H; Sakai K; Matsubara A; Mizuchi A Arzneimittelforschung; 1997 Jun; 47(6):706-9. PubMed ID: 9239447 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic interactions between eperisone hydrochloride and aceclofenac: a randomized, open-label, crossover study of healthy Korean men. Kim MJ; Lim HS; Noh YH; Kim YH; Choi HY; Park KM; Kim SE; Bae KS Clin Ther; 2013 Oct; 35(10):1528-35. PubMed ID: 24050970 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of eperisone in patients with low back pain: a double blind randomized study. Cabitza P; Randelli P Eur Rev Med Pharmacol Sci; 2008; 12(4):229-35. PubMed ID: 18727454 [TBL] [Abstract][Full Text] [Related]
6. Effect of a centrally-acting muscle relaxant, eperisone hydrochloride, on muscle sympathetic nerve activity in humans. Iwase S; Mano T; Saito M; Ishida G Funct Neurol; 1992; 7(6):459-70. PubMed ID: 1338431 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological studies of 1-(2,3-dimethyl-4-methoxyphenyl)-2-methyl-3-(1-pyrrolidinyl)-1- propanone hydrochloride (AD-2239), a centrally acting muscle relaxant. Ito T; Hori M; Furukawa K; Karasawa T; Kadokawa T Arch Int Pharmacodyn Ther; 1985 May; 275(1):105-22. PubMed ID: 3839647 [TBL] [Abstract][Full Text] [Related]
8. [Eperisone hydrochloride in relaxation of accommodation function and improvement of eyestrain in experimental visual tasks]. Iwasaki T; Kurimoto S Nippon Ganka Gakkai Zasshi; 1987 Aug; 91(8):740-6. PubMed ID: 3434464 [No Abstract] [Full Text] [Related]
9. Efficacy and tolerability of eperisone and baclofen in spastic palsy: a double-blind randomized trial. Bresolin N; Zucca C; Pecori A Adv Ther; 2009 May; 26(5):563-73. PubMed ID: 19458926 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological studies of the new centrally acting muscle relaxant 4'-ethyl-2-methyl-3-pyrrolidinopropiophenone hydrochloride. Morikawa K; Oshita M; Yamazaki M; Ohara N; Mizutani F; Kato H; Ito Y; Kontani H; Koshiura R Arzneimittelforschung; 1987 Mar; 37(3):331-6. PubMed ID: 3593447 [TBL] [Abstract][Full Text] [Related]
11. Open experience with a new myorelaxant agent for low back pain. Sartini S; Guerra L Adv Ther; 2008 Oct; 25(10):1010-8. PubMed ID: 18836866 [TBL] [Abstract][Full Text] [Related]
12. Clinical experience with eperisone in the treatment of acute low back pain. Beltrame A; Grangiè S; Guerra L Minerva Med; 2008 Aug; 99(4):347-52. PubMed ID: 18663343 [TBL] [Abstract][Full Text] [Related]
13. Human pharmacokinetics of the muscle relaxant, eperisone hydrochloride by liquid chromatography-electrospray tandem mass spectrometry. Melilli B; Piazza C; Vitale DC; Marano MR; Pecori A; Mattana P; Volsi VL; Iuculano C; Cardì F; Drago F Eur J Drug Metab Pharmacokinet; 2011 Jun; 36(2):71-8. PubMed ID: 21448778 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of eperisone in patients with spastic palsy: a cross-over, placebo-controlled dose-ranging trial. Bresolin N; Zucca C; Pecori A Eur Rev Med Pharmacol Sci; 2009; 13(5):365-70. PubMed ID: 19961042 [TBL] [Abstract][Full Text] [Related]
15. Sigma receptor modulation of the muscle relaxant action of eperisone. Hasegawa Y; Kaku S; Araki H; Otomo S Eur Neuropsychopharmacol; 1992 Jun; 2(2):157-9. PubMed ID: 1353001 [TBL] [Abstract][Full Text] [Related]
16. Effects of a new centrally acting muscle relaxant, NK433 (lanperisone hydrochloride) on spinal reflexes. Sakitama K; Ozawa Y; Aoto N; Tomita H; Ishikawa M Eur J Pharmacol; 1997 Oct; 337(2-3):175-87. PubMed ID: 9430412 [TBL] [Abstract][Full Text] [Related]
17. Influence of ethanol on the myorelaxant effect of diazepam in rats. Bach-Rojecky L; Samarzija I Acta Pharm; 2005 Mar; 55(1):115-22. PubMed ID: 15907229 [TBL] [Abstract][Full Text] [Related]
18. Eperisone Hydrochloride, a Muscle Relaxant, Is a Potent P2X7 Receptor Antagonist. Okada M; Nose T Chem Pharm Bull (Tokyo); 2024; 72(3):345-348. PubMed ID: 38556262 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of eperisone hydrochloride in the treatment of acute musculoskeletal spasm associated with low back pain: a randomized, double-blind, placebo-controlled trial. Chandanwale AS; Chopra A; Goregaonkar A; Medhi B; Shah V; Gaikwad S; Langade DG; Maroli S; Mehta SC; Naikwadi A; Pawar DR J Postgrad Med; 2011; 57(4):278-85. PubMed ID: 22120855 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic Interactions Between Pelubiprofen and Eperisone Hydrochloride: A Randomized, Open-label, Crossover Study of Healthy Korean Men. Ryu JH; Kim JI; Kim HS; Noh GJ; Lee KT; Chung EK Clin Ther; 2017 Jan; 39(1):138-149. PubMed ID: 27989618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]